NYRADA INC. - Corporate Spotlight

Market Cap $16.14M Add to my watchlist

Healthcare

Nyrada Inc is an Australia-based drug development company. The Company focuses on... Nyrada Inc is an Australia-based drug development company. The Company focuses on development of small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. Its drug development programs include a proprotein convertase subtilisin/kexin type nine (PCSK9) inhibitor for the treatment of high blood low-density lipoprotein (LDL)-cholesterol levels in patients poorly responsive to or unable to take statin drugs. It develops a neuroprotectant drug to reduce the impact of long-term disability in patients with ischaemic stroke and traumatic brain injury. The Company also develops a drug to treat pain associated with peripheral nerve damage and autoimmune diseases such as psoriasis.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) is stepping up its trial activities in Australia’s nearest Asian neighbour, Indonesia. Recce’s flagship anti-infective, R327, can be applied as a gel – and this gel-based version of the drug has been of specific interest...

No Corporate Spotlight currently available.

(20min delay)
Last 9.0¢		Change -0.004(4.26%)		Mkt cap ! $16.14M

Open	High	Low	Value	Volume
9.3¢	9.3¢	8.8¢	$107.5K	1.189M

Buyers (Bids)

No.	Vol.	Price($)
1	3163	9.0¢

Sellers (Offers)

Price($)	Vol.	No.
9.2¢	11000	1

View Market Depth

No.	Vol.	Price($)
1	3163	0.090
1	50000	0.089
2	194401	0.088
3	312000	0.087
2	300000	0.086

Price($)	Vol.	No.
0.092	11000	1
0.093	110599	2
0.094	90011	2
0.095	100000	1
0.096	25000	1

Last trade - 15.59pm 03/05/2024 (20 minute delay)


Last 8.9¢		Change -0.004 ( 5.32 %)
Open	High	Low	Volume
9.2¢	9.3¢	8.8¢	553472
Last updated 15.36pm 03/05/2024 ?

NYR (ASX) Chart

NYRADA INC. - Corporate Spotlight

Buyers (Bids)

Sellers (Offers)

Top Stories